|
GTF2E1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.26120011603825E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.80360000001656E-06 |
| Normal-vs-Stage2 |
4.884400E-03 |
| Normal-vs-Stage3 |
1.462450E-03 |
| Normal-vs-Stage4 |
3.396800E-01 |
| Stage1-vs-Stage2 |
3.084800E-01 |
| Stage1-vs-Stage3 |
5.970800E-01 |
| Stage1-vs-Stage4 |
3.831400E-01 |
| Stage2-vs-Stage3 |
6.442400E-01 |
| Stage2-vs-Stage4 |
1.946170E-01 |
| Stage3-vs-Stage4 |
2.565800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.07379948955622E-10 |
| Normal-vs-AfricanAmerican |
1.842320E-04 |
| Normal-vs-Asian |
1.467420E-01 |
| Caucasian-vs-AfricanAmerican |
1.651440E-01 |
| Caucasian-vs-Asian |
8.114200E-01 |
| AfricanAmerican-vs-Asian |
8.331400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.93309998511404E-09 |
| Normal-vs-Female |
4.00340000039634E-07 |
| Male-vs-Female |
5.596000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.173890E-02 |
| Normal-vs-Extreme_Weight |
8.11200000000456E-05 |
| Normal-vs-Obese |
2.31880000000073E-05 |
| Normal-vs-Extreme_Obese |
1.077830E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.021800E-01 |
| Normal_Weight-vs-Obese |
1.545440E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.888400E-01 |
| Extreme_Weight-vs-Obese |
3.104600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.142600E-01 |
| Obese-vs-Extreme_Obese |
6.763000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.69020000000608E-05 |
| Normal-vs-Age(41-60Yrs) |
2.96239999197923E-09 |
| Normal-vs-Age(61-80Yrs) |
7.16930000033145E-07 |
| Normal-vs-Age(81-100Yrs) |
1.570160E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.486000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.172380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.035300E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.582200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.409760E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.729600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.29551966113695E-12 |
| Normal-VS-Type2 PRCC |
2.646000E-02 |
| Normal-VS-KIRP CIMP |
1.084260E-03 |
| Normal-VS-Unclassified PRCC |
1.455140E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.239050E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.532000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.292600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.805700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.233700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.390800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.683700E-03 |
| Normal-vs-N1 |
2.579900E-03 |
| Normal-vs-N2 |
4.953800E-01 |
| N0-vs-N1 |
4.495900E-02 |
| N0-vs-N2 |
6.650200E-01 |
| N1-vs-N2 |
5.501600E-01 |
|
|
